GammaTile Brachytherapy Demonstrates Superior Local Control in Recurrent Brain Metastases

GammaTile achieved 87% local control at 1 year in recurrent brain metastases with 8% toxicity, outperforming historical controls.

GammaTile cesium-131 brachytherapy achieved 87% local control at 1 year in patients with recurrent brain metastases previously treated with stereotactic radiosurgery, with only 8% symptomatic radiation toxicity. This represents a significant improvement over historical recurrence rates of 40% with resection alone and superior outcomes compared to repeat stereotactic surgery (71-75% local control).

Study Design & Population

  • Study type: Retrospective analysis of salvage treatment outcomes
  • Sample size: 31 patients with 38 recurrent brain metastases
  • Patient characteristics: Previously treated with stereotactic radiosurgery, undergoing salvage resection
  • Institution: MD Anderson Cancer Center
  • Treatment: GammaTile cesium-131 collagen tile brachytherapy at time of tumor resection

Key Findings

  • Primary outcome: Cumulative incidence of local failure at 1 year was 13% overall
  • Gross total resection subgroup: 6.4% local failure rate (94% local control)
  • Toxicity profile: 8% symptomatic radiation toxicity incidence
  • Local control rates: 87% overall local control at 1 year, 94% for gross total resection cases

Clinical Implications

  • Superior outcomes: GammaTile demonstrates 80-100% local control rates across multiple studies versus 71-75% with repeat stereotactic surgery
  • Reduced toxicity: Lower symptomatic radiation toxicity compared to conventional re-irradiation approaches
  • Treatment gap closure: Immediate radiation delivery during surgery eliminates delay between resection and post-operative radiation
  • Salvage option: Provides viable treatment for patients with limited re-irradiation options due to prior radiation exposure

Limitations

  • Retrospective design: Single-center, non-randomized analysis limits generalizability
  • Sample size: Relatively small cohort of 31 patients may limit statistical power
  • Follow-up duration: One-year follow-up may not capture long-term outcomes or late toxicities
  • Selection bias: Patients selected for salvage surgery may represent favorable prognostic subgroup

Source: https://link.springer.com/article/10.1007/s11060-025-05113-x

Share the Post:

Related Posts

Join Our Newsletter